Stay updated on Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A page revision/version label was updated from v3.5.2 to v3.5.3. This reflects a systems/UI update rather than a change to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-25T18:25:41.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The revision version was updated from v3.5.0 to v3.5.2. New Study Record Date entries (2026-04-13, 2023-03-10, 2026-04-07, 2026-04) were added, and several earlier dates (2025-03-10, 2025-12, 2025-03-06, 2025-03) were removed.
    Difference
    0.4%
    Check dated 2026-04-18T13:22:43.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed, indicating an internal update to the page rendering. The changes appear to be system-level versioning rather than content changes.
    Difference
    0.1%
    Check dated 2026-03-20T19:49:06.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T17:46:51.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; this is a minor system-level update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:50:42.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Minor site revision from v3.4.0 to v3.4.1 with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:14:13.000Z thumbnail image

Stay in the know with updates to Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.